.png)
Singapore Healthtech Start-up Kyberlife Closes USD 3 Million Investment Round and Sets Sight on Catalyzing Growth for Southeast Asia’s Life Science Sector
- Kyberlife
- Mar 19
- 5 min read
Updated: Mar 26
Singapore, 19 March 2025 – Kyberlife, Singapore’s leading B2B healthcare e-commerce platform, today announced it has raised USD 3 million in its latest investment round led by Singapore venture capital firm 5I Ventures, with participation from East Ventures, A2D Ventures, and NUS Alumni Ventures (NAV). The new capital will support Kyberlife’s regional expansion plans and vision to streamline the digital procurement process within the healthcare sector.
The Asian medical market is booming, with McKinsey predicting that the region will contribute to one-third of global sales by 2025. Despite this growth, new challenges are emerging in the macroeconomic environment, such as shifts in global supply chains and new procurement compliance requirements. These factors have made procuring critical laboratory equipment more complex and lengthy. The industry has historically faced a fragmented procurement process.
To address these challenges, Kyberlife has built an online marketplace that connects research and healthcare suppliers worldwide with laboratories, healthcare institutions, and research centers in Southeast Asia.
Open Digital Marketplace Built by Scientists, for Scientists
Built on a platform-as-a-service (PaaS) model, Kyberlife revolutionizes the sourcing process with its open digital marketplace concept. Featuring 1.2 million products from 160 brands, the platform offers a wide range of items, including laboratory equipment and life-science instruments.
As a one-stop shop, Kyberlife enables academic, research labs, and other healthcare
institutions to acquire critical equipment, rewriting the norm of long sourcing processes, lead times and opaque pricing, that’s typical of traditional procurement processes. By digitizing manual workflows and streamlining the supply chain, the platform has reduced the average procurement time by 40%.
The proprietary technology behind the platform is designed to integrate seamlessly with existing procurement enterprise resource planning systems and direct-to-consumer digital workflows. Over the past year, the company has enhanced the buying and selling experience by incorporating emerging technologies such as data analytics and AI, which help provide personalized product recommendations for customers.
Driving Innovation and Regional Expansion
Kyberlife’s latest funding round will fuel its upcoming phase of regional growth and expansion, focusing on several key initiatives:
Expansion into Indonesia.
Kyberlife will look to onboard Indonesia vendors onto its platform, offering them a platform to expand their business cross-borders and seek new sources of growth.
Connecting Local Healthcare Institutions to Global Suppliers.
The company intends to broaden its network of suppliers and customers in Southeast Asian markets, including Singapore, Indonesia, and Thailand. By introducing new product categories such as laboratory instruments and chemical reagents, Kyberlife seeks to empower local organizations to enhance their R&D efforts in clinical trials and pharmaceutical research across ASEAN. The company aims to grow its vendor portfolio to ten times its current size within the next three years.
Investing in Emerging Technologies.
Kyberlife will also look to invest in technologies like AI to deliver personalized
product recommendations. These advancements will digitalize procurement workflows and close the sustainability gap it takes to find, source, acquire goods.
Since its inception in 2021, Kyberlife has already attracted a distinguished roster of supporters including visionaries like Maya Hari (Former Global Vice President at Twitter), Professor/Dr. Jeremy Lim (Chief Executive Officer, AMiLi), and Dr Michael Gorriz (Former Global CIO of Standard Chartered Bank) who have played pivotal roles in the company’s growth.
"Kyberlife is a platform that is built by scientists, for scientists. Our vision is to simplify the complex and lengthy process researchers face when sourcing laboratory equipment and supplies essential for R&D in the healthcare industry. We are grateful for the continued support and we look forward to connecting more healthcare vendors with institutions to drive R&D efforts in Singapore and in the broader Southeast Asia region", said Ryan James Lim, Co-Founder and CEO, Kyberlife.
"At 5I Ventures, we invest in companies that disrupt industries and provide scalable solutions,” said Dieter Schlosser, Managing Partner at 5I Ventures. “Kyberlife’s innovative approach to procurement is a game-changer for the life sciences sector, and we are proud to back their vision."
"We believe in Kyberlife’s ability to redefine how healthcare institutions, government agencies and laboratories access critical supplies," said Ankit Upadhyay, General Partner of A2D Ventures. "Their platform’s potential to scale and drive innovation in an industry that impacts millions of lives aligns perfectly with our mission to support transformative startups."
"We believe Kyberlife will make a difference in digitizing and streamlining procurement
processes in the healthcare and life sciences space in Southeast Asia and beyond, and at the same time, bring regional healthcare institutions greater access to global suppliers. We are pleased to welcome Kyberlife to the East Ventures ecosystem and look forward to their success," said Wesley Tay, Principal at East Ventures.
To date, the platform has been joined by leading suppliers such as Merck, ZymoResearch, DKSH, Eppendorf, and Sartorius that join over 160 global brands and 1.2 Million SKUs and serves major customers, such as National University Singapore, Duke-NUS, Nanyang Technological University, and National Cancer Centre of Singapore.
About Kyberlife
Kyberlife is a leading healthcare e-commerce platform dedicated to streamlining the
procurement process for medical supplies and pharmaceuticals. By leveraging AI-driven
solutions and data analytics, Kyberlife connects research customers with trusted suppliers, ensuring efficiency, transparency, and cost savings in the healthcare supply chain. Kyberlife was founded and incorporated in Singapore by two Co-Founders: Mr. Ryan James Lim (CEO), and Mr. Michael Tillmann (Chairman), bringing with them diverse expertise in business and tech, and across several industries.
Its Chairman, Mr. Michael Tillmann, has over 25 years of experience in senior executive and supervisory board positions for multinational companies in the pharmaceutical and diagnostics industry. He held the position of President and CEO for Roche Diagnostics in North America and before that, in the Asia Pacific and Europe. While its CEO, previously worked as a research scientist in academia specialising in Metabolomics and Chemistry.
About 5I Ventures
5I Ventures is a Singapore based forward thinking investment firm focusing on empowering visionary tech start-ups across the globe to drive hyper-growth and fast-track their expansion. The team combines deep industry expertise with a commitment to innovation, helping entrepreneurs scale their ideas into market leaders. With a proven track record, 5I Ventures is a trusted partner for young companies seeking to redefine their future.
About East Ventures
East Ventures is a pioneering and leading sector-agnostic venture capital firm. Founded in 2009, East Ventures has transformed into a holistic platform that provides multi-stage investment, from Seed to Growth stage investments, for over 300 tech companies across Southeast Asia.
As an early believer in the startup ecosystem in Indonesia and the most active investor in Southeast Asia, East Ventures is an early backer of prominent tech companies in the region, such as Tokopedia, Traveloka, Ruangguru, ShopBack, waresix, Xendit, IDN, Sociolla, Fore Coffee, Tech in Asia (acquired by SPH), Kudo (acquired by Grab), Loket (acquired by Gojek), and MokaPOS (acquired by Gojek).
East Ventures was named the most consistent top-performing VC fund globally by Preqin and the most active investor in SEA and Indonesia by various media. Moreover, East Ventures is Indonesia's first venture capital firm to sign the Principles of Responsible Investment (PRI), supported by the United Nations (UN). East Ventures is committed to achieving sustainable development and positively impacting society through its initiatives and ESG-embedded practices.
About A2D Ventures
A2D Ventures is Southeast Asia’s prominent early-stage venture capital firm, angel syndicate, and angel investing platform with a mission to democratize venture capital. Their platform enables global investors to back innovative and impactful companies across various sectors, with a focus on supporting entrepreneurs who are building the future of Southeast Asia.
Media Contacts:
Ryan James Lim
Chief Executive Officer, Kyberlife
Summer Panichpanao
Marketing Team, Kyberlife
Comments